Skip to main content
. 2013 Sep 8;14:189. doi: 10.1186/1471-2369-14-189

Table 2.

Biochemical data from patients dialysing against different dialysate calcium concentrations

Dialysate calcium 1.0 mmol/l 1.25 mmol/l 1.35 mmol/l ≥ 1.5 mmol/l
Calcium
2.3 ± 0.17
2.3 ± 0.17
2.25 ± 0.17
2.23 ± 0.16
Calcium corr
2.45 ± 0.17
2.47 ± 0.16
2.43 ± 0.15
2.40 ± 0.13
Phosphate
1.62 ± 0.43*
1.48 ± 0.51*
1.48 ± 0.48*
1.08 ± 0.3
Albumin g/l
39.3 ± 3.3
41.1 ± 3.7*+
39.4 ± 4.2
38.1 ± 3.7
ALP
128(89–180)
87(71–113)
96(69–138)
91(73–108)
PTH
45(22–77)*+
31(15–51)
24(13–52)
16(10–26)
TChol
3.8 ± 1.0
4.0 ± 0.17
4.0 ± 1.0
3.9 ± 1.0
HDL
1.23 ± 0.33
1.28 ± 0.40
1.31 ± 0.55
1.02 ± 0.38
LDL
1.86 ± 0.89
2.09 ± 0.80
2.07 ± 0.94
2.04 ± 0.84
TG
1.40(0.8-1.93)
1.20(0.9-1.1)
1.20(0.9-1.9)
1.65(1.1-2.58)
Statin (%)
48.2
59.3
61
61.9
Calcium
0(0–1.28)*
1.5(0–1.5)
1.0(0–3.0)
1.0(0–3.0)
Sevelamer
0(0–1.0)*
0(0–0)
0(0–0)
0(0–0)
Lanthanum
0(0–250)
0(0–0)
0(0–0)
0(0–0)
Cinacalcet
0(0–30)*
0(0–0)
0(0–0)
0(0–0)
Calcitriol
3(0.94-5.25)
3(0.75-5.25)
1.75(0.75-4.5)
1.5(0.-3)
PTX (%) 5.6 8.3 1.7 0

Data expressed in mmol/l unless otherwise stated. Calcium (measured calcium), calcium corrected for serum albumin (Calcium corr), alkaline phosphatase IU/L (ALP), parathyroid hormone pmol/l (PTH), total cholesterol (TChol), high density lipoprotein (HDL), low density lipoprotein (LDL), triglycerides (TG). Drug prescription: HMG CoA3reductase (statin), calcium carbonate (Calcium) g/day, sevelamer g/day, lanthanum carbonate (lanthanum) g/day, calcitriol (ug/wk), and cinacalcet mg/day, percentage patients with parathyroidectomy (PTX). Results expressed as percentage (%), mean ± SD, or median (interquartile range). Patients dialysing with dialysate calcium 1.5 mmol/l (n = 17) added to those dialysing using calcium 1.75 mmol/l (n = 4) summated due to low numbers. *p < 0.05 by Chi square analysis or anova with post hoc correction vs high dialysate calcium (≥1.5 mmol/l) and + p < 0.05 vs calcium dialysate 1.35 mmol/l.